ReP USP - Resultado da busca

Artigo de periodico
Islet transplantation: overcoming the organ shortage (2023)
Mantovani, Marluce da Cunha ; Gabanyi, Ilana ; Pantanali, Carlos Andrés ; Santos, Vinicius Rocha; Giannella, Maria Lucia Cardillo Correa ; Sogayar, Mari Cleide
Source: Diabetology and Metabolic Syndrome. Unidades: FM, IQ
Subjects: DIABETES MELLITUS, PÂNCREAS, TRANSPLANTE DE PÂNCREAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MANTOVANI, Marluce da Cunha et al. Islet transplantation: overcoming the organ shortage. Diabetology and Metabolic Syndrome, v. 15, p. 1-8 art. 144, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13098-023-01089-8. Acesso em: 11 nov. 2024.
APA
Mantovani, M. da C., Gabanyi, I., Pantanali, C. A., Santos, V. R., Giannella, M. L. C. C., & Sogayar, M. C. (2023). Islet transplantation: overcoming the organ shortage. Diabetology and Metabolic Syndrome, 15, 1-8 art. 144. doi:10.1186/s13098-023-01089-8
NLM
Mantovani M da C, Gabanyi I, Pantanali CA, Santos VR, Giannella MLCC, Sogayar MC. Islet transplantation: overcoming the organ shortage [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-8 art. 144.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-023-01089-8
Vancouver
Mantovani M da C, Gabanyi I, Pantanali CA, Santos VR, Giannella MLCC, Sogayar MC. Islet transplantation: overcoming the organ shortage [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-8 art. 144.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-023-01089-8
Artigo de periodico
Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study (2023)
Toyoshima, Marcos Tadashi Kakitani ; Santana, Monique de Fatima Mello; Silva, Amanda R. M; Mello, Gabriela B; Bezerra, Daniele P. Santos; Góes, Marisa F. S; Bosco, Adriana A; Caramelli, Bruno ; Ronsein, Graziella Eliza ; Giannella, Maria Lucia Correa ; Passarelli, Marisa
Source: Diabetology and Metabolic Syndrome. Unidades: FM, IQ
Subjects: PROTEÔMICA, DIABETES MELLITUS, ARTERIOSCLEROSE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOYOSHIMA, Marcos Tadashi Kakitani et al. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study. Diabetology and Metabolic Syndrome, v. 15, p. 1-14 art. 42, 2023Tradução . . Disponível em: https://doi.org/10.1186/s13098-023-01007-y. Acesso em: 11 nov. 2024.
APA
Toyoshima, M. T. K., Santana, M. de F. M., Silva, A. R. M., Mello, G. B., Bezerra, D. P. S., Góes, M. F. S., et al. (2023). Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study. Diabetology and Metabolic Syndrome, 15, 1-14 art. 42. doi:10.1186/s13098-023-01007-y
NLM
Toyoshima MTK, Santana M de FM, Silva ARM, Mello GB, Bezerra DPS, Góes MFS, Bosco AA, Caramelli B, Ronsein GE, Giannella MLC, Passarelli M. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-14 art. 42.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-023-01007-y
Vancouver
Toyoshima MTK, Santana M de FM, Silva ARM, Mello GB, Bezerra DPS, Góes MFS, Bosco AA, Caramelli B, Ronsein GE, Giannella MLC, Passarelli M. Proteomics of high-density lipoprotein subfractions and subclinical atherosclerosis in type 1 diabetes mellitus: a case–control study [Internet]. Diabetology and Metabolic Syndrome. 2023 ; 15 1-14 art. 42.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-023-01007-y
Artigo de periodico
Health literacy and glycemic control in patients with diabetes: a tertiary care center study in Brazil (2020)
Gomes, Marilia B; Muniz, Luiza Harcar; Melo, Laura Gomes Nunes; Pizarro, Marcela Haas; Barros, Bianca Senger Vasconcelos; Santos, Deborah Conte; Negrato, Carlos Antonio
Source: Diabetology and Metabolic Syndrome. Unidade: FOB
Subjects: DIABETES MELLITUS, GLICEMIA, EDUCAÇÃO EM SAÚDE, EDUCAÇÃO EM SAÚDE, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GOMES, Marilia B et al. Health literacy and glycemic control in patients with diabetes: a tertiary care center study in Brazil. Diabetology and Metabolic Syndrome, v. 12, p. 11, 2020Tradução . . Disponível em: https://doi.org/10.1186/s13098-020-0519-6. Acesso em: 11 nov. 2024.
APA
Gomes, M. B., Muniz, L. H., Melo, L. G. N., Pizarro, M. H., Barros, B. S. V., Santos, D. C., & Negrato, C. A. (2020). Health literacy and glycemic control in patients with diabetes: a tertiary care center study in Brazil. Diabetology and Metabolic Syndrome, 12, 11. doi:10.1186/s13098-020-0519-6
NLM
Gomes MB, Muniz LH, Melo LGN, Pizarro MH, Barros BSV, Santos DC, Negrato CA. Health literacy and glycemic control in patients with diabetes: a tertiary care center study in Brazil [Internet]. Diabetology and Metabolic Syndrome. 2020 ;12 11.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-020-0519-6
Vancouver
Gomes MB, Muniz LH, Melo LGN, Pizarro MH, Barros BSV, Santos DC, Negrato CA. Health literacy and glycemic control in patients with diabetes: a tertiary care center study in Brazil [Internet]. Diabetology and Metabolic Syndrome. 2020 ;12 11.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-020-0519-6
Artigo de periodico
Diabetic retinopathy among Brazilian Xavante Indians (2018)
Lima, Carlos Gustavo M. G.; Franco, Laércio Joel; Dal-Fabbro, Amaury Lelis; Martinez, Edson Zangiacomi; Veira-Filho, João Paulo Botelho; Ventura, Alexandre A. C. M.; Prevelato, Leonardo; Cruz, Antônio Augusto Velasco
Source: Diabetology and Metabolic Syndrome. Unidade: FMRP
Subjects: DOENÇAS RETINIANAS, DIABETES MELLITUS, ÍNDIOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Carlos Gustavo M. G. et al. Diabetic retinopathy among Brazilian Xavante Indians. Diabetology and Metabolic Syndrome, v. 10, n. 1, 2018Tradução . . Disponível em: https://doi.org/10.1186/s13098-018-0348-z. Acesso em: 11 nov. 2024.
APA
Lima, C. G. M. G., Franco, L. J., Dal-Fabbro, A. L., Martinez, E. Z., Veira-Filho, J. P. B., Ventura, A. A. C. M., et al. (2018). Diabetic retinopathy among Brazilian Xavante Indians. Diabetology and Metabolic Syndrome, 10( 1). doi:10.1186/s13098-018-0348-z
NLM
Lima CGMG, Franco LJ, Dal-Fabbro AL, Martinez EZ, Veira-Filho JPB, Ventura AACM, Prevelato L, Cruz AAV. Diabetic retinopathy among Brazilian Xavante Indians [Internet]. Diabetology and Metabolic Syndrome. 2018 ; 10( 1):[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-018-0348-z
Vancouver
Lima CGMG, Franco LJ, Dal-Fabbro AL, Martinez EZ, Veira-Filho JPB, Ventura AACM, Prevelato L, Cruz AAV. Diabetic retinopathy among Brazilian Xavante Indians [Internet]. Diabetology and Metabolic Syndrome. 2018 ; 10( 1):[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-018-0348-z
Artigo de periodico
Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) (2017)
Bertoluci, Marcello Casaccia; Moreira, Rodrigo Oliveira; Faludi, André; Izar, Maria Cristina; Schaan, Beatriz D.; Valerio, Cynthia Melissa; Bertolami, Marcelo Chiara; Chacra, Ana Paula; Malachias, Marcus Vinicius Bolivar; Vencio, Sérgio; Saraiva, José Francisco Kerr; Betti, Roberto; Turatti, Luiz; Fonseca, Francisco Antonio Helfenstein; Bianco, Henrique Tria; Sulzbach, Marta; Bertolami, Adriana; Salles, João Eduardo Nunes; Hohl, Alexandre; Trujilho, Fábio; Lima, Eduardo Gomes; Miname, Marcio Hiroshi; Zanella, Maria Teresa; Lamounier, Rodrigo; Sá, João Roberto; Amodeo, Celso; Pires, Antonio Carlos; Santos, Raul D.
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: DIABETES MELLITUS, GUIAS, DOENÇAS CARDIOVASCULARES, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTOLUCI, Marcello Casaccia et al. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetology and Metabolic Syndrome, v. 9, n. 53, p. 36 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s13098-017-0251-z. Acesso em: 11 nov. 2024.
APA
Bertoluci, M. C., Moreira, R. O., Faludi, A., Izar, M. C., Schaan, B. D., Valerio, C. M., et al. (2017). Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM). Diabetology and Metabolic Syndrome, 9( 53), 36 . doi:10.1186/s13098-017-0251-z
NLM
Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 53): 36 .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-017-0251-z
Vancouver
Bertoluci MC, Moreira RO, Faludi A, Izar MC, Schaan BD, Valerio CM, Bertolami MC, Chacra AP, Malachias MVB, Vencio S, Saraiva JFK, Betti R, Turatti L, Fonseca FAH, Bianco HT, Sulzbach M, Bertolami A, Salles JEN, Hohl A, Trujilho F, Lima EG, Miname MH, Zanella MT, Lamounier R, Sá JR, Amodeo C, Pires AC, Santos RD. Brazilian guidelines on prevention of cardiovascular disease in patients with diabetes: a position statement from the Brazilian Diabetes Society (SBD), the Brazilian Cardiology Society (SBC) and the Brazilian Endocrinology and Metabolism Society (SBEM) [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 53): 36 .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-017-0251-z
Artigo de periodico
Tissue-specific methylation profile in obese patients with type 2 diabetes before and after Roux-en-Y gastric bypass (2017)
Sala, Priscila; Torrinhas, Raquel Susana Matos de Miranda; Fonseca, Danielle Cristina; Ravacci, Graziela Rosa; Waitzberg, Dan Linetzky; Giannella-Neto, Daniel
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: OBESIDADE, METILAÇÃO DE DNA, EPIGÊNESE GENÉTICA, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SALA, Priscila et al. Tissue-specific methylation profile in obese patients with type 2 diabetes before and after Roux-en-Y gastric bypass. Diabetology and Metabolic Syndrome, v. 9, n. 15, p. 15 , 2017Tradução . . Disponível em: https://doi.org/10.1186/s13098-017-0214-4. Acesso em: 11 nov. 2024.
APA
Sala, P., Torrinhas, R. S. M. de M., Fonseca, D. C., Ravacci, G. R., Waitzberg, D. L., & Giannella-Neto, D. (2017). Tissue-specific methylation profile in obese patients with type 2 diabetes before and after Roux-en-Y gastric bypass. Diabetology and Metabolic Syndrome, 9( 15), 15 . doi:10.1186/s13098-017-0214-4
NLM
Sala P, Torrinhas RSM de M, Fonseca DC, Ravacci GR, Waitzberg DL, Giannella-Neto D. Tissue-specific methylation profile in obese patients with type 2 diabetes before and after Roux-en-Y gastric bypass [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 15): 15 .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-017-0214-4
Vancouver
Sala P, Torrinhas RSM de M, Fonseca DC, Ravacci GR, Waitzberg DL, Giannella-Neto D. Tissue-specific methylation profile in obese patients with type 2 diabetes before and after Roux-en-Y gastric bypass [Internet]. Diabetology and Metabolic Syndrome. 2017 ; 9( 15): 15 .[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/s13098-017-0214-4
Artigo de periodico
Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study (2016)
Parisi, Maria Candida R.; Moura Neto, Arnaldo; Menezes, Fabio H.; Gomes, Marilia Brito; Teixeira, Rodrigo Martins; Oliveira, José Egídio Paulo de; Pereira, Joana Rodrigues Dantas; Fonseca, Reine Marie Chaves; Guedes, Lorena Barreto Arruda; Forti, Adriana Costa e; Oliveira, Ana Mayra Andrade de; Nóbrega, Marta Barreto de Medeiros; Colares, Víctor Nóbrega Quintas; Schmid, Helena; Nienov, Otto Henrique; Nery, Marcia; Fernandes, Túlio Diniz; Pedrosa, Hermelinda C.; Oliveira, Cristina da S. Schreiber de; Ronsoni, Marcelo; Rezende, Karla Freire; Quilici, Maria Teresa Verrone; Vieira, Alexandre Eduardo Franzin; Macedo, Geisa Maria Campos de; Stuchi‑Perez, Eliana Gabas; Dinhane, Kandir Genésio Innocenti; Pace, Ana Emilia ; Freitas, Maria Cristina Foss de; Calsolari, Maria Regina; Saad, Mario José Abdalla
Source: Diabetology and Metabolic Syndrome. Unidades: FM, EERP, FMRP
Subjects: DIABETES MELLITUS, FATORES DE RISCO, NEUROPATIAS DIABÉTICAS, PÉ DIABÉTICO, BRASIL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PARISI, Maria Candida R. et al. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetology and Metabolic Syndrome, v. 8, p. 8 , 2016Tradução . . Disponível em: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-016-0126-8. Acesso em: 11 nov. 2024.
APA
Parisi, M. C. R., Moura Neto, A., Menezes, F. H., Gomes, M. B., Teixeira, R. M., Oliveira, J. E. P. de, et al. (2016). Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetology and Metabolic Syndrome, 8, 8 . doi:10.1186/s13098-016-0126-8
NLM
Parisi MCR, Moura Neto A, Menezes FH, Gomes MB, Teixeira RM, Oliveira JEP de, Pereira JRD, Fonseca RMC, Guedes LBA, Forti AC e, Oliveira AMA de, Nóbrega MB de M, Colares VNQ, Schmid H, Nienov OH, Nery M, Fernandes TD, Pedrosa HC, Oliveira C da SS de, Ronsoni M, Rezende KF, Quilici MTV, Vieira AEF, Macedo GMC de, Stuchi‑Perez EG, Dinhane KGI, Pace AE, Freitas MCF de, Calsolari MR, Saad MJA. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study [Internet]. Diabetology and Metabolic Syndrome. 2016 ; 8 8 .[citado 2024 nov. 11 ] Available from: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-016-0126-8
Vancouver
Parisi MCR, Moura Neto A, Menezes FH, Gomes MB, Teixeira RM, Oliveira JEP de, Pereira JRD, Fonseca RMC, Guedes LBA, Forti AC e, Oliveira AMA de, Nóbrega MB de M, Colares VNQ, Schmid H, Nienov OH, Nery M, Fernandes TD, Pedrosa HC, Oliveira C da SS de, Ronsoni M, Rezende KF, Quilici MTV, Vieira AEF, Macedo GMC de, Stuchi‑Perez EG, Dinhane KGI, Pace AE, Freitas MCF de, Calsolari MR, Saad MJA. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study [Internet]. Diabetology and Metabolic Syndrome. 2016 ; 8 8 .[citado 2024 nov. 11 ] Available from: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-016-0126-8
Artigo de periodico
Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study (2016)
Tostes, Glauce Cordeiro Ulhôa; Cunha, Maria Rosário; Fukui, Rosa Tsumeshiro; Correia, Márcia Regina Silva; Rocha, Dalva Marreiro; Santos, Rosa Ferreira dos; Silva, Maria Elizabeth Rossi da
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: BIOMARCADORES, INFLAMAÇÃO, FÁRMACOS IMUNOSSUPRESSORES, METABOLISMO, DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
TOSTES, Glauce Cordeiro Ulhôa et al. Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study. Diabetology and Metabolic Syndrome, v. 8, p. 9 , 2016Tradução . . Disponível em: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-015-0120-6. Acesso em: 11 nov. 2024.
APA
Tostes, G. C. U., Cunha, M. R., Fukui, R. T., Correia, M. R. S., Rocha, D. M., Santos, R. F. dos, & Silva, M. E. R. da. (2016). Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study. Diabetology and Metabolic Syndrome, 8, 9 . doi:10.1186/s13098-015-0120-6
NLM
Tostes GCU, Cunha MR, Fukui RT, Correia MRS, Rocha DM, Santos RF dos, Silva MER da. Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study [Internet]. Diabetology and Metabolic Syndrome. 2016 ; 8 9 .[citado 2024 nov. 11 ] Available from: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-015-0120-6
Vancouver
Tostes GCU, Cunha MR, Fukui RT, Correia MRS, Rocha DM, Santos RF dos, Silva MER da. Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study [Internet]. Diabetology and Metabolic Syndrome. 2016 ; 8 9 .[citado 2024 nov. 11 ] Available from: http://dmsjournal.biomedcentral.com/articles/10.1186/s13098-015-0120-6
Artigo de periodico
Diabetes and cardiovascular disease: From evidence to clinical practice - Position statement 2014 of Brazilian Diabetes Society (2014)
Bertoluci, Marcello Casaccia; Pimazoni-Netto, Augusto; Pires, Antonio Carlos; Pesaro, Antonio Eduardo; Schaan, Beatriz D.; Caramelli, Bruno; Polanczyk, Carisi Anne; Serrano Júnior, Carlos Vicente; Gualandro, Danielle M.; Malerbi, Domingos Augusto; Moriguchi, Emilio; Borelli, Flavio Antonio de Oliveira; Salles, João Eduardo Nunes; Mariani Júnior, José; Rohde, Luis Eduardo; Canani, Luis H.; Cesar, Luiz Antonio Machado; Tambascia, Marcos; Zanella, Maria Tereza; Gus, Miguel; Scheffel, Rafael Selbach; Santos, Raul Dias dos
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: HIPERTENSÃO, DIABETES MELLITUS, REVASCULARIZAÇÃO MIOCÁRDICA, DISLIPIDEMIAS (TERAPIA), DOENÇAS CARDIOVASCULARES
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BERTOLUCI, Marcello Casaccia et al. Diabetes and cardiovascular disease: From evidence to clinical practice - Position statement 2014 of Brazilian Diabetes Society. Diabetology and Metabolic Syndrome, v. 6, n. 58, p. (online), 2014Tradução . . Disponível em: https://doi.org/10.1186/1758-5996-6-58. Acesso em: 11 nov. 2024.
APA
Bertoluci, M. C., Pimazoni-Netto, A., Pires, A. C., Pesaro, A. E., Schaan, B. D., Caramelli, B., et al. (2014). Diabetes and cardiovascular disease: From evidence to clinical practice - Position statement 2014 of Brazilian Diabetes Society. Diabetology and Metabolic Syndrome, 6( 58), (online). doi:10.1186/1758-5996-6-58
NLM
Bertoluci MC, Pimazoni-Netto A, Pires AC, Pesaro AE, Schaan BD, Caramelli B, Polanczyk CA, Serrano Júnior CV, Gualandro DM, Malerbi DA, Moriguchi E, Borelli FA de O, Salles JEN, Mariani Júnior J, Rohde LE, Canani LH, Cesar LAM, Tambascia M, Zanella MT, Gus M, Scheffel RS, Santos RD dos. Diabetes and cardiovascular disease: From evidence to clinical practice - Position statement 2014 of Brazilian Diabetes Society [Internet]. Diabetology and Metabolic Syndrome. 2014 ; 6( 58): (online).[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/1758-5996-6-58
Vancouver
Bertoluci MC, Pimazoni-Netto A, Pires AC, Pesaro AE, Schaan BD, Caramelli B, Polanczyk CA, Serrano Júnior CV, Gualandro DM, Malerbi DA, Moriguchi E, Borelli FA de O, Salles JEN, Mariani Júnior J, Rohde LE, Canani LH, Cesar LAM, Tambascia M, Zanella MT, Gus M, Scheffel RS, Santos RD dos. Diabetes and cardiovascular disease: From evidence to clinical practice - Position statement 2014 of Brazilian Diabetes Society [Internet]. Diabetology and Metabolic Syndrome. 2014 ; 6( 58): (online).[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/1758-5996-6-58
Artigo de periodico
Fibronectin glycation increases IGF-I induced proliferation of human aortic smooth muscle cells (2012)
Corrêa-Giannella, Maria L.; Azevedo, Maria Regina A. de; LeRoith, Derek; Giannella-Neto, Daniel
Source: Diabetology and Metabolic Syndrome. Unidade: FM
Subjects: FIBRONECTINAS, DIABETES MELLITUS, MÚSCULO LISO, FATORES DE CRESCIMENTO, PROLIFERAÇÃO CELULAR
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CORRÊA-GIANNELLA, Maria L. et al. Fibronectin glycation increases IGF-I induced proliferation of human aortic smooth muscle cells. Diabetology and Metabolic Syndrome, v. 4, n. 19, p. (online), 2012Tradução . . Disponível em: https://doi.org/10.1186/1758-5996-4-19. Acesso em: 11 nov. 2024.
APA
Corrêa-Giannella, M. L., Azevedo, M. R. A. de, LeRoith, D., & Giannella-Neto, D. (2012). Fibronectin glycation increases IGF-I induced proliferation of human aortic smooth muscle cells. Diabetology and Metabolic Syndrome, 4( 19), (online). doi:10.1186/1758-5996-4-19
NLM
Corrêa-Giannella ML, Azevedo MRA de, LeRoith D, Giannella-Neto D. Fibronectin glycation increases IGF-I induced proliferation of human aortic smooth muscle cells [Internet]. Diabetology and Metabolic Syndrome. 2012 ; 4( 19): (online).[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/1758-5996-4-19
Vancouver
Corrêa-Giannella ML, Azevedo MRA de, LeRoith D, Giannella-Neto D. Fibronectin glycation increases IGF-I induced proliferation of human aortic smooth muscle cells [Internet]. Diabetology and Metabolic Syndrome. 2012 ; 4( 19): (online).[citado 2024 nov. 11 ] Available from: https://doi.org/10.1186/1758-5996-4-19
Artigo de periodico
Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola (2010)
Evaristo Neto, António Dias Assunção; Freitas, Maria Cristina Foss de; Foss, Milton César
Source: Diabetology and Metabolic Syndrome. Unidade: FMRP
Assunto: DIABETES MELLITUS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
EVARISTO NETO, António Dias Assunção e FREITAS, Maria Cristina Foss de e FOSS, Milton César. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola. Diabetology and Metabolic Syndrome, v. 2, n. 1, p. 63-67, 2010Tradução . . Acesso em: 11 nov. 2024.
APA
Evaristo Neto, A. D. A., Freitas, M. C. F. de, & Foss, M. C. (2010). Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola. Diabetology and Metabolic Syndrome, 2( 1), 63-67.
NLM
Evaristo Neto ADA, Freitas MCF de, Foss MC. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola. Diabetology and Metabolic Syndrome. 2010 ; 2( 1): 63-67.[citado 2024 nov. 11 ]
Vancouver
Evaristo Neto ADA, Freitas MCF de, Foss MC. Prevalence of diabetes mellitus and impaired glucose tolerance in a rural community of Angola. Diabetology and Metabolic Syndrome. 2010 ; 2( 1): 63-67.[citado 2024 nov. 11 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Funding Agencies

Indexado em